- Home
- DRRX vs ICUCW Comparison
DRRX vs ICUCW Comparison
Compare DRRX & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRRX
- ICUCW
- Stock Information
- Founded
- DRRX 1998
- ICUCW N/A
- Country
- DRRX United States
- ICUCW United States
- Employees
- DRRX N/A
- ICUCW 19
- Industry
- DRRX Biotechnology: Pharmaceutical Preparations
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- DRRX Health Care
- ICUCW Health Care
- Exchange
- DRRX Nasdaq
- ICUCW Nasdaq
- Market Cap
- DRRX N/A
- ICUCW N/A
- IPO Year
- DRRX 2000
- ICUCW 2021
- Fundamental
- Price
- DRRX $1.85
- ICUCW $0.04
- Analyst Decision
- DRRX Hold
- ICUCW
- Analyst Count
- DRRX 1
- ICUCW 0
- Target Price
- DRRX N/A
- ICUCW N/A
- AVG Volume (30 Days)
- DRRX 2.8M
- ICUCW N/A
- Earning Date
- DRRX 08-12-2025
- ICUCW N/A
- Dividend Yield
- DRRX N/A
- ICUCW N/A
- EPS Growth
- DRRX N/A
- ICUCW N/A
- EPS
- DRRX N/A
- ICUCW N/A
- Revenue
- DRRX $1,856,000.00
- ICUCW N/A
- Revenue This Year
- DRRX N/A
- ICUCW N/A
- Revenue Next Year
- DRRX $673.00
- ICUCW N/A
- P/E Ratio
- DRRX N/A
- ICUCW N/A
- Revenue Growth
- DRRX 79.84
- ICUCW N/A
- 52 Week Low
- DRRX $0.48
- ICUCW N/A
- 52 Week High
- DRRX $2.64
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- DRRX 85.21
- ICUCW N/A
- Support Level
- DRRX $1.82
- ICUCW N/A
- Resistance Level
- DRRX $2.64
- ICUCW N/A
- Average True Range (ATR)
- DRRX 0.10
- ICUCW 0.00
- MACD
- DRRX 0.14
- ICUCW 0.00
- Stochastic Oscillator
- DRRX 62.74
- ICUCW 0.00
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.